{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:13:59Z","timestamp":1765887239653},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,7,12]],"date-time":"2010-07-12T00:00:00Z","timestamp":1278892800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>In the course of producing the 2009 NHS Evidence - skin disorders Annual Evidence Update on Acne Vulgaris, 25 randomised controlled trials were examined. From these, at least 12 potentially serious problems of trial reporting were identified. Several trials concluded no effect of a treatment yet they were insufficiently powered to exclude potentially useful benefits. There were examples of duplicate publication and \"salami publication\", as well as two trials being combined and reported as one. In some cases, an incorrect \"within-groups\" statistical comparison was made and one trial report omitted original efficacy data and included only P values. Both of the non-inferiority studies examined failed to pre-specify a non-inferiority margin. Trials reported as \"double-blind\" compared treatments that were dissimilar in appearance or had differing adverse effect profiles. In one case an intention-to-treat analysis was not performed and there was a failure to account for all of the randomized participants. Trial results were made to sound more impressive by selective outcome reporting, emphasizing the statistical significance of treatment effects that were clinically insignificant, and by the use of larger-sounding odds ratios rather than rate ratios for common events. Most of the reporting problems could have been avoided by use of the CONSORT guidelines and prospective trial registration on a public clinical trials database.<\/jats:p>","DOI":"10.1186\/1745-6215-11-77","type":"journal-article","created":{"date-parts":[[2010,7,29]],"date-time":"2010-07-29T01:50:45Z","timestamp":1280368245000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Problems in the reporting of acne clinical trials: a spot check from the 2009 Annual Evidence Update on Acne Vulgaris"],"prefix":"10.1186","volume":"11","author":[{"given":"John R","family":"Ingram","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas JC","family":"Grindlay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hywel C","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,12]]},"reference":[{"key":"488_CR1","unstructured":"2009 Annual Evidence Update on Acne Vulgaris - Home Page. [http:\/\/www.library.nhs.uk\/SKIN\/ViewResource.aspx?resID=306605&tabID=289&catID=8275]"},{"key":"488_CR2","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1001\/jama.294.2.218","volume":"294","author":"JP Ioannidis","year":"2005","unstructured":"Ioannidis JP: Contradicted and initially stronger effects in highly cited clinical research. JAMA. 2005, 294: 218-228. 10.1001\/jama.294.2.218.","journal-title":"JAMA"},{"key":"488_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1365-2230.2009.03683.x","volume":"35","author":"JR Ingram","year":"2010","unstructured":"Ingram JR, Grindlay DJ, Williams HC: Management of acne vulgaris: an evidence-based update. Clin Exp Dermatol. 2010, 35: 351-4. 10.1111\/j.1365-2230.2009.03683.x.","journal-title":"Clin Exp Dermatol"},{"key":"488_CR4","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1525-1470.2007.00604.x","volume":"25","author":"RW Short","year":"2008","unstructured":"Short RW, Agredano YZ, Choi JM, Kimball AB: A single-blinded, randomized pilot study to evaluate the effect of exercise-induced sweat on truncal acne. Pediatr Dermatol. 2008, 25: 126-128. 10.1111\/j.1525-1470.2007.00604.x.","journal-title":"Pediatr Dermatol"},{"key":"488_CR5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.4103\/0378-6323.39727","volume":"74","author":"R Dhir","year":"2008","unstructured":"Dhir R, Gehi NP, Agarwal R, More YE: Oral isotretinoin is as effective as a combination of oral isotretinoin and topical anti-acne agents in nodulocystic acne. Indian J Dermatol Venereol Leprol. 2008, 74: 187-10.4103\/0378-6323.39727.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"488_CR6","doi-asserted-by":"publisher","first-page":"715","DOI":"10.7326\/0003-4819-132-9-200005020-00006","volume":"132","author":"WL Greene","year":"2000","unstructured":"Greene WL, Concato J, Feinstein AR: Claims of equivalence in medical research: are they supported by the evidence?. Ann Intern Med. 2000, 132: 715-722.","journal-title":"Ann Intern Med"},{"key":"488_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jdermsci.2007.11.005","volume":"50","author":"RN Smith","year":"2008","unstructured":"Smith RN, Braue A, Varigos GA, Mann NJ: The effect of a low glycemic load diet on acne vulgaris and the fatty acid composition of skin surface triglycerides. J Dermatol Sci. 2008, 50: 41-52. 10.1016\/j.jdermsci.2007.11.005.","journal-title":"J Dermatol Sci"},{"key":"488_CR8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/ajcn\/86.1.107","volume":"86","author":"RN Smith","year":"2007","unstructured":"Smith RN, Mann NJ, Braue A, Makelainen H, Varigos GA: A low-glycemic-load diet improves symptoms in acne vulgaris patients: a randomized controlled trial. Am J Clin Nutr. 2007, 86: 107-115.","journal-title":"Am J Clin Nutr"},{"key":"488_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jaad.2007.01.046","volume":"57","author":"RN Smith","year":"2007","unstructured":"Smith RN, Mann NJ, Braue A, Makelainen H, Varigos GA: The effect of a high-protein, low glycemic-load diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: a randomized, investigator-masked, controlled trial. J Am Acad Dermatol. 2007, 57: 247-256. 10.1016\/j.jaad.2007.01.046.","journal-title":"J Am Acad Dermatol"},{"key":"488_CR10","unstructured":"2008 National Knowledge Week on Acne Vulgaris - Homepage. [http:\/\/www.library.nhs.uk\/skin\/Page.aspx?pagename=ACNEHOME]"},{"key":"488_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.contraception.2007.11.003","volume":"77","author":"W Koltun","year":"2008","unstructured":"Koltun W, Lucky AW, Thiboutot D, Niknian M, Sampson-Landers C, Korner P, Marr J: Efficacy and safety of 3 mg drospirenone\/20 mcg ethinylestradiol oral contraceptive administered in 24\/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trial. Contraception. 2008, 77: 249-256. 10.1016\/j.contraception.2007.11.003.","journal-title":"Contraception"},{"key":"488_CR12","first-page":"143","volume":"82","author":"AW Lucky","year":"2008","unstructured":"Lucky AW, Koltun W, Thiboutot D, Niknian M, Sampson-Landers C, Korner P, Marr J: A combined oral contraceptive containing 3-mg drospirenone\/20-microg ethinyl estradiol in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled study evaluating lesion counts and participant self-assessment. Cutis. 2008, 82: 143-150.","journal-title":"Cutis"},{"key":"488_CR13","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/j.1365-4632.2009.04002.x","volume":"48","author":"EH Spencer","year":"2009","unstructured":"Spencer EH, Ferdowsian HR, Barnard ND: Diet and acne: a review of the evidence. Int J Dermatol. 2009, 48: 339-347. 10.1111\/j.1365-4632.2009.04002.x.","journal-title":"Int J Dermatol"},{"key":"488_CR14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ajo.2007.04.047","volume":"144","author":"KR Wilhelmus","year":"2007","unstructured":"Wilhelmus KR: Redundant publication of clinical trials on herpetic keratitis. Am J Ophthalmol. 2007, 144: 222-226. 10.1016\/j.ajo.2007.04.047.","journal-title":"Am J Ophthalmol"},{"key":"488_CR15","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1001\/archdermatol.2007.35","volume":"144","author":"PE Koch","year":"2008","unstructured":"Koch PE, Ryder HF, Dziura J, Njike V, Antaya RJ: Educating adolescents about acne vulgaris: a comparison of written handouts with audiovisual computerized presentations. Arch Dermatol. 2008, 144: 208-214. 10.1001\/archdermatol.2007.35.","journal-title":"Arch Dermatol"},{"key":"488_CR16","first-page":"1757","volume":"29","author":"KE Sharquie","year":"2008","unstructured":"Sharquie KE, Noaimi AA, Al-Salih MM: Topical therapy of acne vulgaris using 2% tea lotion in comparison with 5% zinc sulphate solution. Saudi Med J. 2008, 29: 1757-1761.","journal-title":"Saudi Med J"},{"key":"488_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1467-842X.2004.tb00623.x","volume":"28","author":"K Jamrozik","year":"2004","unstructured":"Jamrozik K: Of sausages and salami. Aust N Z J Public Health. 2004, 28: 5-6. 10.1111\/j.1467-842X.2004.tb00623.x.","journal-title":"Aust N Z J Public Health"},{"key":"488_CR18","unstructured":"ClinicalTrials.gov. Trial Identifier NCT00469755. [http:\/\/www.clinicaltrials.gov\/ct2\/results?term=NCT00469755]"},{"key":"488_CR19","first-page":"s18","volume":"7","author":"D Pariser","year":"2008","unstructured":"Pariser D, Colon LE, Johnson LA, Gottschalk RW: Adapalene 0.1% gel compared to tazarotene 0.1% cream in the treatment of acne vulgaris. J Drugs Dermatol. 2008, 7: s18-23.","journal-title":"J Drugs Dermatol"},{"key":"488_CR20","first-page":"s11","volume":"7","author":"LS Gold","year":"2008","unstructured":"Gold LS, Colon LE, Johnson LA, Gottschalk RW: Is switching retinoids a sound strategy for the treatment of acne vulgaris?. J Drugs Dermatol. 2008, 7: s11-17.","journal-title":"J Drugs Dermatol"},{"key":"488_CR21","first-page":"1149","volume":"7","author":"P Toossi","year":"2008","unstructured":"Toossi P, Farshchian M, Malekzad F, Mohtasham N, Kimyai-Asadi A: Subantimicrobial-dose doxycycline in the treatment of moderate facial acne. J Drugs Dermatol. 2008, 7: 1149-1152.","journal-title":"J Drugs Dermatol"},{"key":"488_CR22","first-page":"171","volume":"81","author":"S Raimer","year":"2008","unstructured":"Raimer S, Maloney JM, Bourcier M, Wilson D, Papp K, Siegfried E, Garrett S: Efficacy and safety of dapsone gel 5% for the treatment of acne vulgaris in adolescents. Cutis. 2008, 81: 171-178.","journal-title":"Cutis"},{"key":"488_CR23","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jaad.2008.06.040","volume":"59","author":"D Thiboutot","year":"2008","unstructured":"Thiboutot D, Zaenglein A, Weiss J, Webster G, Calvarese B, Chen D: An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and safety in 2813 patients. J Am Acad Dermatol. 2008, 59: 792-800. 10.1016\/j.jaad.2008.06.040.","journal-title":"J Am Acad Dermatol"},{"key":"488_CR24","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.jaad.2009.06.077","volume":"61","author":"KA Katz","year":"2009","unstructured":"Katz KA, Kim CY, Williams HC: Reporting clinical trials: why one plus one does not equal two. J Am Acad Dermatol. 2009, 61: 1082-1083. 10.1016\/j.jaad.2009.06.077.","journal-title":"J Am Acad Dermatol"},{"key":"488_CR25","first-page":"433","volume":"18","author":"J Marcinkiewicz","year":"2008","unstructured":"Marcinkiewicz J, Wojas-Pelc A, Walczewska M, Lipko-Godlewska S, Jachowicz R, Maciejewska A, Bialecka A, Kasprowicz A: Topical taurine bromamine, a new candidate in the treatment of moderate inflammatory acne vulgaris: a pilot study. Eur J Dermatol. 2008, 18: 433-439.","journal-title":"Eur J Dermatol"},{"key":"488_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1468-2494.2008.00479.x","volume":"31","author":"C Ruamrak","year":"2009","unstructured":"Ruamrak C, Lourith N, Natakankitkul S: Comparison of clinical efficacies of sodium ascorbyl phosphate, retinol and their combination in acne treatment. Int J Cosmet Sci. 2009, 31: 41-46. 10.1111\/j.1468-2494.2008.00479.x.","journal-title":"Int J Cosmet Sci"},{"key":"488_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.4103\/0019-5154.37721","volume":"52","author":"L Ghoshal","year":"2007","unstructured":"Ghoshal L, Banerjee S, Ghosh SK, Gangopadhyay DN, Jana S: Comparative evaluation of effectiveness of adapalene and azithromycin, alone or in combination, in acne vulgaris. Indian Journal of Dermatology. 2007, 52: 179-183. 10.4103\/0019-5154.37721.","journal-title":"Indian Journal of Dermatology"},{"key":"488_CR28","first-page":"534","volume":"7","author":"E Tanghetti","year":"2008","unstructured":"Tanghetti E, Kircik L, Wilson D, Dhawan S: Solubilized benzoyl peroxide versus benzoyl peroxide\/clindamycin in the treatment of moderate acne. J Drugs Dermatol. 2008, 7: 534-538.","journal-title":"J Drugs Dermatol"},{"key":"488_CR29","first-page":"737","volume":"7","author":"H Ansarin","year":"2008","unstructured":"Ansarin H, Savabynasab S, Behzadi AH, Sadigh N, Hasanloo J: Doxycycline plus levamisole: combination treatment for severe nodulocystic acne. J Drugs Dermatol. 2008, 7: 737-740.","journal-title":"J Drugs Dermatol"},{"key":"488_CR30","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1001\/archderm.142.6.761","volume":"142","author":"KA Katz","year":"2006","unstructured":"Katz KA: The (relative) risks of using odds ratios. Arch Dermatol. 2006, 142: 761-764. 10.1001\/archderm.142.6.761.","journal-title":"Arch Dermatol"},{"key":"488_CR31","doi-asserted-by":"crossref","unstructured":"Schulz KF, Altman DG, Moher D: CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Trials. 11: 32-10.1186\/1745-6215-11-32.","DOI":"10.1186\/1745-6215-11-32"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-11-77.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1745-6215-11-77\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-11-77","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-11-77.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T12:13:39Z","timestamp":1630498419000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/1745-6215-11-77"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,12]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["488"],"URL":"https:\/\/doi.org\/10.1186\/1745-6215-11-77","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,12]]},"assertion":[{"value":"15 April 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"77"}}